5th Annual Young Investigators Forum in Lung Cancer

Developing the Next Generation of Leaders

W Atlanta - Midtown
188 14th St NE
Atlanta, Georgia 30361

Submit Your Abstract Eligibility & Criteria


Medscape is dedicated to providing timely, accurate, and clinically meaningful education for healthcare providers. We also appreciate the important role our faculty and learners play in healthcare as well as the challenges associated with the novel Coronavirus (COVID-19) pandemic. As a result, the Young Investigators Forum in Lung Cancer planned for September 11-12, 2020 will be postponed to a later date. We will provide an update as soon as the Forum has been rescheduled, including information regarding the new application period.


The 5th Annual Young Investigators Forum in Lung Cancer will provide an opportunity for collegial interaction with other young investigators and established senior investigators in lung cancer.

The Forum is specifically designed for young investigators who are pursuing a career in academic research in lung cancer. The goal is help prepare the young investigators to succeed in translational and clinical research. An engaging agenda includes relevant and stimulating presentations for the young-investigator audience, but also allows ample time for discussion and debate with senior-investigator faculty, networking, small-group sessions, and breakout tracks.

The faculty-to-young-investigator ratio is low to encourage one-on-one and small-group discussions, networking, and face-to-face time. Young investigators each present their own research, for which they receive feedback and commentary. Additionally, selected attendees present cases offering treatment recommendations, and senior investigators weigh in with their opinions and feedback.

The deadline to submit abstracts is July 20, 2020.

Click here to view criteria.

Key Indicators of Success

Previous attendees indicated that the Young Investigators Forum:

  • Helped them in their career (100%)
  • Prepared them for career success (100%)
  • Enabled them to make a connection for research projects (90%)

Each year the co-chairs, Drs Julie Brahmer and Suresh Ramalingam, work to keep the content fresh and applicable for all attendees.

View Infographic

Meet the Faculty

Click on the photos to view bios.


Julie Brahmer, MD, MSc, FASCO
Suresh Ramalingam, MD


Swipe sideways to scroll.

Shirish Gadgeel, MD
Justin F. Gainor, MD
Jhanelle Gray, MD
Nasser Hanna, MD
Leora Horn, MD, MDc
Natasha Leighl, MD, MMSc, FRCPC, FASCO
Gregory J. Riely, MD, PhD
Joan H. Schiller, MD

Keynote Speakers

Amy Moghanaki
Gary L. Teal, MBA


Time Event
7:00 AM Registration and Breakfast
7:45 AM Plenary Session I – Writing and Responding
9:30 AM Abstract Presentations
12:30 PM Lunch
1:30 PM Breakout Sessions
3:10 PM Plenary Session II – Professional Skills
4:45 PM Adjourn
5:00 PM Office Hours
7:00 PM Reception and Dinner
Time Event
7:00 AM Breakfast
7:45 AM Plenary Session III – Clinical Cases and Updates
9:35 AM Top 4 Abstract Presentations
11:15 AM Breakout Sessions I
11:45 AM Lunch
12:45 PM Breakout Sessions II
1:15 PM Concluding Session and Announcement of Winners
1:30 PM Adjourn

Past Meetings

2019 Atlanta


2018 Atlanta


2017 Atlanta


2016 Chicago


Target Audience

The target audience for this activity includes medical oncologist junior faculty (MD or DO who has completed a fellowship within the past 5 years) and fellows (actively enrolled in a fellowship program) who are pursuing careers in lung cancer.

Learning Objectives

Upon completion of this activity, participants will:

  • Have greater competence related to
    • Assessing the rationales, design, and endpoints in clinical trials investigating treatment options for lung cancer
    • Selecting treatment for lung cancer based upon disease and patient characteristics
  • Demonstrate greater confidence in their ability to
    • Evaluate recent data from national society meetings that have the potential to impact practice

Get in Touch With Us

Do you have any questions? Please do not hesitate to contact us directly. Our team is happy to assist you.